889
Participants
Start Date
June 28, 2024
Primary Completion Date
March 31, 2026
Study Completion Date
March 31, 2026
Icodextrin Peritoneal Dialysis Solution
The treatment modality, treatment frequency, treatment dose, duration of dwell, and length of treatment, as determined and supervised by a prescribing physician experienced in treating ESRD with PD.
Glucose Peritoneal Dialysis Solution
The treatment modality, number of daily dialysate exchanges, dialysate concentration, exchange dosage of dialysate, duration of dwell, and length of treatment for PD patients as determined by the clinician.
RECRUITING
Beijing Haidian Hospital, Beijing
RECRUITING
Shanghai General Hospital, Shanghai
RECRUITING
Renji Hospital Shanghai Jaotong University School of Medicine, Shanghai
RECRUITING
Nanjing Drum Tower Hospital, Jiangse
RECRUITING
Wuxi People's Hospital, Jiangse
RECRUITING
The Second Affiliated Hospital of Soochow University, Suzhou
RECRUITING
The First People's Hospital of Kunshan, Jiangse
RECRUITING
Hangzhou Hospital Of Traditional Chinese Medicine, Hangzhou
RECRUITING
Ningbo First Hospital, Ningbo
RECRUITING
The Affiliated Hospital of Inner Mongolia Medical University, Hohhot
Baxter Healthcare Corporation
INDUSTRY
Vantive Health LLC
INDUSTRY